Archive for August 5, 2008

invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that its DiaryPRO® field-based ePRO system was used to capture primary efficacy endpoint data in the recently unblinded Phase III study of Pollinex® Quattro, a vaccine being developed by Allergy Therapeutics® plc (AIM:AGY) to treat the symptoms Read the rest of this entry »

May is National Asthma and Allergy Awareness Month, and Carpenter Co., a leader in sleep technologies and the world’s largest producer of comfort cushion products, offers relief for the more than 60 million Americans who suffer from these ailments. The company’s innovative SlumberFresh™ pillow is filled with RELY™ fiber, which protects the pillow and mattress pad against Read the rest of this entry »

Expectant mothers who eat nuts or nut products like peanut butter daily during pregnancy increase their children’s risk of developing asthma by more than 50 percent over women who rarely or never consume nut products during pregnancy, according to new research from the Netherlands.
"We were pretty surprised to see the adverse associations between daily Read the rest of this entry »

High living standards and the life style connected to them seem to promote the development of autoimmune diseases and allergic symptoms. This has lead to the assumption that the immune system begins to overreact to the organism’s own structures or to exogenous non-infectious Read the rest of this entry »

Morria Biopharmaceuticals Plc, a
biopharmaceutical company focused on the development of novel
anti-inflammatory drugs, announced that it has obtained regulatory
approval from the South African Medicines Control Council (MCC) to initiate
a Phase II study of MRX-4 in 105 patients suffering from Read the rest of this entry »